Fund Holdings — Merck & Co., Inc.

Total Portfolio Value:
$526.41M
Total Bought:
$25.61M
Total Sold:
$33.30M
Net Transaction:
-$7.69M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Personalis, Inc.(PSNL)14,044,94314,044,9430$89.47M$188.20M35.75%+$98.74M
Moderna, Inc.(MRNA)2,308,1902,308,1900$117.26M$161.64M30.71%+$44.39M
Kymera Therapeutics, Inc.(KYMR)772,165772,1650$64.31M$88.54M16.82%+$24.23M
Aktis Oncology, Inc.(AKTS)952,844952,8440$17.05M$30.71M5.83%+$13.66M
EIKON THERAPEUTICS INC1,666,6661,666,6660$17.63M$21.75M4.13%+$4.12M
ENTRADA THERAPEUTICS INC01,739,768+1,739,768$0$12.80M2.43%+$12.80M
SUTRO BIOPHARMA INC0272,351+272,351$0$9.04M1.72%+$9.04M
ALECTOR INC3,545,7193,545,7190$7.62M$7.13M1.35%-$496.4K
EVAXION BIOTECH A/S01,214,126+1,214,126$0$3.76M0.71%+$3.76M
Viridian Therapeutics, Inc.(VRDN)93,41493,4140$1.83M$1.72M0.33%-$111.2K
XILIO THERAPEUTICS INC105,982105,9820$891.3K$1.02M0.19%+$124.0K
TUHURA BIOSCIENCES INC19,44519,4450$34.8K$45.5K0.01%+$10.7K
NEUPHORIA THERAPEUTICS INC10,02710,0270$40.8K$43.8K0.01%+$3.0K
CARISMA THERAPEUTICS INC1,473,2400-1,473,240$47.9K$0—-$47.9K
ENTRADA THERAPEUTICS INC1,739,7680-1,739,768$21.96M$0—-$21.96M
EVAXION BIOTECH A/S1,214,1260-1,214,126$4.52M$0—-$4.52M
SUTRO BIOPHARMA INC272,3510-272,351$6.78M$0—-$6.78M
Page 1 of 1
Merck & Co., Inc. — 13F Holdings — Q2 2026 | TickerTrail